Clinical Study
Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus
Table 2
Overall clinical and biological data at 1- and 3-year followup.
| Variable | Before surgery | 1 year after surgery | 3 years after surgery | value |
| BMI kg/m2 | 45.0 ± 6.8 | 29.7 ± 6.5 | 31.6 ± 4.4 | <.0001 | HbA1c % | 5.8 ± 1.1 | 5.3 ± 0.5 | 5.4 ± 1.2 | <.0001 | AST level U/L | 22.7 ± 11.9 | 18.14 ± 9.9 | 20.0 ± 10.8 | <.0001 | ALT level U/L | 34.2 ± 21.2 | 19.8 ± 14.8 | 23.01 ± 17.2 | <.0001 | Triglyceride level mmol/L | 1.6 ± 1.1 | 1.0 ± 0.4 | 1.0 ± 0.5 | <.0001 | Cholesterol level mmol/L | 5.1 ± 1.1 | 5.1 ± 1.0 | 5.1 ± 1.3 | NS | LDL level mmol/L | 3.1 ± 0.8 | 3.1 ± 1.0 | 3.1 ± 1.6 | NS | HDL level mmol/L | 1.3 ± 0.5 | 1.26 ± 0.5 | 1.6 ± 0.4 | <.0001 |
|
|
Figures presented as mean ± standard deviation; value determined with Kruskal-Wallis test.
|